Publications by authors named "F Mastroleo"

Purpose: To investigate the awareness and the spread of ChatGPT and its possible role in both scientific research and clinical practice among the young radiation oncologists (RO).

Material And Methods: An anonymous, online survey via Google Forms (including 24 questions) was distributed among young (< 40 years old) ROs in Italy through the yAIRO network, from March 15, 2024, to 31, 2024. These ROs were officially registered with yAIRO in 2023.

View Article and Find Full Text PDF

Regenerative life support systems for space crews recycle waste into water, food, and oxygen using different organisms. The European Space Agency's MELiSSA program uses the cyanobacterium Limnospira indica PCC8005 for air revitalization and food production. Before space use, components' compatibility with reduced gravity was tested.

View Article and Find Full Text PDF
Article Synopsis
  • The review examines how online medical resources and AI tools are changing radiation oncology practices by enhancing clinical decision-making.* -
  • A search of several databases identified 70 relevant studies that demonstrate the integration of web-based tools in various aspects of radiation therapy, including calculations and educational needs.* -
  • The findings indicate that these digital tools can improve personalized cancer treatment strategies, particularly across different cancer types, with a focus on breast and head & neck cancers.*
View Article and Find Full Text PDF

Spirulina is the commercial name for edible cyanobacteria of the genus . The taxonomy of this genus is confusing with four species distributed in two lineages. Furthermore, the species has been cited as toxic by potentially producing microcystins.

View Article and Find Full Text PDF

Bone metastases (BMs) are the most common cause of cancer-related pain and radiation therapy plays a key role in treating pain caused by it. The half-body irradiation (HBI) is a modality that can be used to treat patients with multiple painful BMs. In the modern era, concerns about toxicity and the availability of new agents requiring robust bone marrow function have limited the use of HBI in advanced cancer.

View Article and Find Full Text PDF